These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7980174)

  • 1. Hepatitis C.
    Steven ID; Gill JS; Hall R
    Aust Fam Physician; 1994 Sep; 23(9):1747-8. PubMed ID: 7980174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical aspects and diagnosis of hepatitis C].
    Leifeld L; Spengler U; Sauerbruch T
    Dtsch Med Wochenschr; 2000 Dec; 125(48):1471-4. PubMed ID: 11153417
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C. Understanding the issues.
    Miller SK
    Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C in children.
    Sehgal S; Jackson Allen PL
    Pediatr Nurs; 2004; 30(5):409-13. PubMed ID: 15587536
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection.
    Tsubota A; Chayama K; Ikeda K; Yasuji A; Koida I; Saitoh S; Hashimoto M; Iwasaki S; Kobayashi M; Hiromitsu K
    Hepatology; 1994 May; 19(5):1088-94. PubMed ID: 8175130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon therapy in renal allograft recipients with chronic hepatitis C.
    Harihara Y; Kurooka Y; Yanagisawa T; Kuzuhara K; Otsubo O; Kumada H
    Transplant Proc; 1994 Aug; 26(4):2075. PubMed ID: 8066675
    [No Abstract]   [Full Text] [Related]  

  • 7. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening and treatment of acute hepatitis C].
    Grangé JD
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):285-7. PubMed ID: 12700513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C: natural history, biology, treatment monitoring].
    Poynard T
    Pathol Biol (Paris); 1999 Nov; 47(9):911-6. PubMed ID: 10609271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C, diagnosis and therapy].
    Moradpour D; Blum HE
    Med Klin (Munich); 1996 Dec; 91(12):769-70. PubMed ID: 9082162
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic viral hepatitis.
    Alexander G; Walsh K
    Int J Clin Pract; 2000 Sep; 54(7):450-6. PubMed ID: 11070570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of chronic hepatitis C virus infection.
    Booth JC; Brown JL; Thomas HC
    Gut; 1995 Oct; 37(4):449-54. PubMed ID: 7489926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].
    Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
    Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatitis C.
    NIH Consens Statement; 1997 Mar 24-26; 15(3):1-41. PubMed ID: 9457159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapy.
    Bruno S; Manzin A; Roncalli M; Petroni ML; Rossi S; Pedicino M; Larghi A; Crosignani A; Podda M
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):31-7. PubMed ID: 9265576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.